Disability

Alterity Therapeutics Reports Positive Interim Data from ATH434-202 Phase 2 Clinical Trial in Multiple System Atrophy

– 43% of Participants Showed Improvement on the UMSARS Activities of Daily Living Scale – – 29% of Participants had…

1 year ago

Trethera Receives $2M NIH Grant for Preclinical Development in the Pediatric Neurologic Disease Acute Disseminated Encephalomyelitis

LOS ANGELES, July 16, 2024 (GLOBE NEWSWIRE) -- Trethera Corporation, a clinical stage biopharmaceutical company committed to developing novel drugs…

1 year ago

Med-Metrix Announces the Acquisition of HRSI, Augmenting the Company’s Eligibility Management Capabilities

PARSIPPANY, N.J., July 15, 2024 /PRNewswire/ -- Med-Metrix, LLC ("Med-Metrix", or the "Company"), a leading provider of technology-enabled, Revenue Cycle…

1 year ago

Guidehouse and HIMSS Partner with the Missouri DHSS on Digital Health Assessment

First of its Kind Initiative to Guide Future Improvements in Data Collection, Management, and Utilization to Enhance Efficiencies and Improve…

1 year ago

R.O.S.A. from Trusaic Optimizes Pay Equity Remediation Efforts

Game-changing PayParity® tool optimizes salary adjustments tomaximize ROI and impact on employees LOS ANGELES, July 10, 2024 /PRNewswire/ -- Trusaic's…

1 year ago

Cresilon’s Revolutionary Hemostatic Gel Technology Shows Promising Results for Treatment of Penetrating Traumatic Brain Injury in Study Performed with Walter Reed Army Institute of Research

Findings from preclinical study demonstrate potential for a field and prehospital treatment following a penetrating TBI NEW YORK, July 9,…

1 year ago

Leading Medical Claims Management provider, Medlogix, LLC Announces the Acquisition of ReviewWorks

HAMILTON, N.J., July 8, 2024 /PRNewswire/ -- Medlogix, LLC, a leading, national medical claims management solutions provider, announced today that…

1 year ago

Veru to Participate in the Leerink Therapeutics Forum: I&I and Metabolism

MIAMI, FL, July 02, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on…

1 year ago

Emergent BioSolutions Awarded $250+ Million in Contract Modifications to Supply U.S. Government with Four Critical Medical Countermeasure Products

GAITHERSBURG, Md., July 02, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has received more than…

1 year ago

South Dakota Partners with Trualta to Support Family Caregivers

All caregivers in the state can access free resources at home PIERRE, S.D., June 27, 2024 /PRNewswire/ --The South Dakota…

1 year ago